Terminated PHASE1/PHASE2 INTERVENTIONAL NCT00226889

Treatment of Early Systemic Sclerosis by Bosentan (TRANOS)

Sponsor: Rikshospitalet University Hospital

Conditions Systemic Sclerosis (Scleroderma)

Interventions bosentan

Updated 5 times since 2017 Last updated: Jun 11, 2009 Started: Jan 31, 2005 Primary completion: Jan 31, 2009 Completion: Jun 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

failure of recruiting a sufficient number of patients

Listed as NCT00226889, this PHASE1/PHASE2 trial focuses on Systemic Sclerosis (Scleroderma) and remains terminated or withdrawn. Sponsored by Rikshospitalet University Hospital, it has been updated 5 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1_PHASE2

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rikshospitalet University Hospital

Data source: Rikshospitalet University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway